Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trialAlfonso Gómez‐Iturriaga, Juanita Crook, F. Casquero et al.|Radiotherapy and Oncology|2016Cited by 79
Fibroblast activation protein predicts prognosis in clear cell renal cell carcinomaJosé I. López, Gorka Larrinaga, J.C. Angulo et al.|Human Pathology|2016Cited by 60
Immune checkpoint B7‐H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancerCaroline E. Nunes‐Xavier, José I. López, Wanja Kildal et al.|The Prostate|2021Cited by 29
Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancerCaroline E. Nunes‐Xavier, José I. López, Maite Emaldi et al.|Pathology - Research and Practice|2022Cited by 25
Precise definition of PTEN C-terminal epitopes and its implications in clinical oncologyJanire Mingo, Rafael Pulido, Sandra Luna et al.|npj Precision Oncology|2019Cited by 22